»áÕ¹Ãû³Æ | 2011Äê¹ú¼ÊTϸ°ûÁÜ°ÍÁöÂÛ̳£¨TLF£© |
²¼Õ¹Ê±¼ä | 2011Äê1ÔÂ26ÈÕ |
Õ¹ÀÀʱ¼ä | 2011Äê1ÔÂ27ÈÕ—2011Äê1ÔÂ29ÈÕ |
³·Õ¹Ê±¼ä | 2011Äê1ÔÂ30ÈÕ |
»áÕ¹³¡¹Ý |
¾É½ðɽ |
Ö÷°ìµ¥Î» | |
³Ð°ìµ¥Î» | |
а쵥λ | |
»áÕ¹Àà±ð | |
ËùÔÚµØÇø |
ÃÀ¹ú ¾É½ðɽ |
»áÕ¹ÃèÊö |
This forum will provide a platform for discussion about the classification, epidemiology, prognosis, and pathogenesis of several T-cell lymphoma subtypes. In addition, the latest information on novel agents and treatment approaches will be presented by T-cell lymphoma experts. This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma. |
²ÎÕ¹·ÑÓà |
¡¡ |
¹ã¸æ·ÑÓà |
¡¡ |
Õ¹»áÖÜÆÚ |
ÿÄêÒ»½ì |
Õ¹»á¹æÄ£ |
¡¡ |
×¢ÒâÊÂÏî |
|
ÁªÏµ·½Ê½ |
×Éѯµç»°: 8610-66054455 8610-51294800 |